URGN
UROGEN PHARMA (URGN)
NASDAQ
$41.42+$0.87 (+2.13%)
Price as of Oct 02, 2026 4:10 PM EDT
  • $1.9B
    Market Cap
  • 137.55%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 52
Valuation
URGN
vs History
vs S&P 500
Profitability
-0
Growth
0
Low Earnings Volatility
1

Momentum Score

Score: 90
Valuation
URGN
vs History
vs S&P 500
3-Month Momentum
17.91%
12-Month Momentum
143.56%
3-Month Risk Adjusted Momentum
72.58%
12-Month Risk Adjusted Momentum
229.42%

True Yield

N/A
Valuation
URGN
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
0.11%

Financial Health Score

Score: 80
Valuation
URGN
vs History
vs S&P 500
Ohlson's O-Score
4